Diagnostics News and Research

RSS

USC researcher wins NIH grant to study how the cochlea processes complex sounds

USC researcher Karolina Charaziak, PhD, has been awarded a $3.3 million National Institutes of Health (NIH) Research Project (R01) grant to study how the cochlea, the part of the inner ear responsible for hearing, processes complex sounds encountered in everyday life.

7 Jul 2026

Beckman Coulter Diagnostics expands Alzheimer’s portfolio with CE-marked p-Tau217 blood test and new high-specificity research assay

Beckman Coulter Diagnostics, a global leader in clinical diagnostics and a Danaher company, today announced it received CE Mark under IVDR for its Access p-Tau217 assay, a blood test designed to support clinical evaluation of amyloid pathology in patients with signs and symptoms of cognitive decline.

7 Jul 2026

Countable Labs and Promega announce co-marketing agreement to facilitate end-to end biological sample preparation and rare variant detection

Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures biology, announced a co-marketing agreement with Promega, a leader in providing innovative solutions and technical support to the life sciences industry.

From Promega Corporation 7 Jul 2026

MGI Tech showcases expanding genomics ecosystem at ESHG 2026 with new IVD partnering program and OEM collaborations

At ESHG 2026, MGI Tech presents cutting-edge genomics solutions, emphasizing automation and partnerships to enhance clinical workflows and precision medicine.

From MGI 6 Jul 2026

New analysis reveals biological features of treatment-resistant aggressive lymphoma

Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified how particularly aggressive forms of lymphoma can be recognized.

3 Jul 2026

WHO launches PARTNERS clinical trial for Bundibugyo virus treatments

In a major international effort to evaluate potential treatments for Ebola disease due to Bundibugyo virus (BVD), the PARTNERS clinical trial has opened enrolment today for patients in the Democratic Republic of the Congo.

3 Jul 2026

Foodborne threats demand stronger pandemic planning, review says

A Perspective review in npj Science of Food argues that pandemics can weaken food safety systems even when the pathogen is not foodborne. The authors call for One Health planning that integrates food safety into pandemic preparedness, surveillance, laboratory capacity, workforce readiness, and regulation.

2 Jul 2026

Engineered CAR T cells show promise against myeloproliferative neoplasms

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving stem cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, in new research led by UCL and University of Oxford researchers.

1 Jul 2026

New national program targeting harmful and unnecessary medicine use in Australia

...

1 Jul 2026

New diagnostic tool bypasses blood-brain barrier to detect autism early

A study published in NeuroMarkers showed that a nanosensor can measure nitric oxide (NO) from patient-derived stem cells to distinguish autism spectrum disorder (ASD) from intellectual disability (ID), even when both conditions share the exact same genetic mutation.

30 Jun 2026

Pharmacy expert calls for hybrid digital-human models in NHS healthcare

A pharmacy academic from Kingston University has provided special expertise to the UK Parliament on two key Health and Social Care Committee inquiries.

30 Jun 2026

New Alzheimer drug lecanemab brings modest benefits and high risks

Canada recently approved lecanemab to treat early Alzheimer disease, but the clinical benefits are modest, it carries a risk of serious adverse effects, and treatment is complex.

29 Jun 2026

Simple blood test could identify the most effective obesity drug

Fasting blood tests measuring GLP-1 and GIP levels may predict obesity treatment response to semaglutide and tirzepatide, enhancing personalized therapy.

29 Jun 2026

New project investigates gut microbiome for personalized bowel disease therapies

The gut microbiome plays an important role in inflammatory bowel disease. In the research project MikrobiomProCheck, researchers are investigating how microbiome data can in future be used for diagnostics, disease monitoring and personalized therapies.

26 Jun 2026

Merck KGaA, Darmstadt, Germany, agrees to acquire Bio-Techne, strengthening leadership position in fast-growing life sciences markets

Merck KGaA, Darmstadt, Germany, a leading science and technology company, and Bio-Techne Corporation, a Minneapolis-based global provider of life science tools, analytical technologies, and consumables, today entered into a definitive agreement pursuant to which Merck KGaA, Darmstadt, Germany, will, subject to customary closing conditions, acquire Bio-Techne for US$73 per share in cash, representing a total enterprise value of approximately US$11.3 billion (EUR 9.9 billion), a 36% premium to Bio-Techne's one-month volume weighted average trading price.

From Bio-Techne 25 Jun 2026

Diagnostics News and Research

USC researcher wins NIH grant to study how the cochlea processes complex sounds

Beckman Coulter Diagnostics expands Alzheimer’s portfolio with CE-marked p-Tau217 blood test and new high-specificity research assay

Countable Labs and Promega announce co-marketing agreement to facilitate end-to end biological sample preparation and rare variant detection

MGI Tech showcases expanding genomics ecosystem at ESHG 2026 with new IVD partnering program and OEM collaborations

New analysis reveals biological features of treatment-resistant aggressive lymphoma

WHO launches PARTNERS clinical trial for Bundibugyo virus treatments

Foodborne threats demand stronger pandemic planning, review says

Engineered CAR T cells show promise against myeloproliferative neoplasms

New national program targeting harmful and unnecessary medicine use in Australia

New diagnostic tool bypasses blood-brain barrier to detect autism early

Pharmacy expert calls for hybrid digital-human models in NHS healthcare

New Alzheimer drug lecanemab brings modest benefits and high risks

Simple blood test could identify the most effective obesity drug

New project investigates gut microbiome for personalized bowel disease therapies

Merck KGaA, Darmstadt, Germany, agrees to acquire Bio-Techne, strengthening leadership position in fast-growing life sciences markets

NVIDIA announces BioNeMo Agent Toolkit — Tools for agents to accelerate scientific discovery

Open source tool automates data reanalysis to detect rare diseases

Using blood proteomics to identify pediatric inflammatory bowel disease risk

LMU researchers discover new genetic cause of Crohn's disease

A window into the body – Occuity harnesses Renishaw encoders in life-changing optical health screening devices

Industry Focus eBook - Biotechnology (4th edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News